Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...
Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases; ...
Novartis to acquire San Diego-based, biopharma company, Avidity Biosciences: Basel Monday, October 27, 2025, 13:30 Hrs [IST] Novartis announced that it has entered into an agreeme ...
Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis ...
Basel: Novartis has announced that it has entered into an agreement to acquire Avidity Biosciences, Inc., a San Diego-based, biopharmaceutical company focused on a new class of ...
Frogs have made significant contributions to Fred Hutch science over the years as a model organism that shares much of our ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...
Q: I’m slated to retire next year, and it scares me to death — well, I hope not death, exactly, but I’m not sure what to do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback